Nutex Health Inc. · NASDAQ:NUTX

Nutex Health — Investor Presentation (January 2024)

25 slides from Nutex Health's investor presentation, Jan 11, 2024

  1. Slide 1: Strictly Private and Confidential

    S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L S T R I C T L Y P R I V A T E A N D C O N F I D E N T I A L

  2. Slide 2: General disclaimer

    C O N F I D E N T I A L 2 General The information contained in this Investor Presentation (“Presentation”) has been prepared by Nutex Health Inc. (“NUTX” or the “Company”) for investors, solely for informational purposes. The Presentation has been prepared to assist prospective investors in making t

  3. Slide 3: Forward looking statements

    C O N F I D E N T I A L 3 Certain statements and information included in this Presentation constitute "forward-looking statements" within the meaning of the Private Securities Litigation Act of 1995. When used in this Presentation, the words or phrases “will”, "will likely result," "expected to," "w

  4. Slide 4: Agenda

    C O N F I D E N T I A L 5 Agenda 1 Business Overview 2 Appendix

  5. Slide 5: Management Team With Deep Experience in Healthcare

    C O N F I D E N T I A L 6 Josh DeTillio Chief Operating Officer Thomas T. Vo, M.D., MBA Chief Executive Officer Jon Bates, MBA, CPA Chief Financial Officer Warren Hosseinion, M.D. President Pamela Montgomery, R.N., J.D. Chief Legal Officer (Healthcare) & Secretary Michael Chang, M.D. Chief Medical O

  6. Slide 6: Investment Highlights

    C O N F I D E N T I A L 7 Investment Highlights Well-positioned for major trends in a large and attractive market (high-quality, medium-acuity patient-centric hospital with inpatient care and value-based outpatient care) 1 Deep value proposition to the healthcare ecosystem from our comprehensive por

  7. Slide 7: Our mission, vision, and values

    C O N F I D E N T I A L 8 Our mission, vision, and values To make exceptional concierge-level health care more accessible to all communities, with a practice centered on patient experience and satisfaction Our Mission To be leaders in individualized patient care and innovators in the future of healt

  8. Slide 8: Nutex at-a-glance

    C O N F I D E N T I A L 9 Nutex at-a-glance ◼ Owns and operates a comprehensive and integrated care delivery platform comprised of: ◼ Hospital Division – Develops and operates a network of micro-hospitals, specialty hospitals, and hospital outpatient departments – A micro-hospital is a small hospita

  9. Slide 9: Overview of Nutex's hospital division

    C O N F I D E N T I A L 10 Overview of Nutex’s hospital division Nutex’s Innovative Micro-Hospitals Meet their served Communities Demand for Higher Acuity Care What we do  Network of strategically located, state-of-the-art micro-hospitals across the U.S. which service ER visits at equivalent cost 

  10. Slide 10: Nutex's micro-hospitals treat over 95% of ER acuities at a fraction of the wait time

    C O N F I D E N T I A L 11 Nutex’s micro-hospitals treat over 95% of ER acuities at a fraction of the wait time Abdominal Pain Chest Pain Broken Bones Injuries and Wounds Flue-like Symptoms Vomiting / Diarrhea Cough Headaches Young adults (18~35) Represents ~31% of patients 1 Source: CDC, National H

  11. Slide 11: Turn-key de novo strategy delivering scalable facility economics

    C O N F I D E N T I A L 12 Turn-key de novo strategy delivering compelling and scalable facility economics De Novo Facility Profile De Novo Rollout Timeline Services / Staffing ◼ Provide emergency, inpatient care, outpatient imaging, outpatient labs, minor procedures, etc. ◼ ER Physician, RNs, Radio

  12. Slide 12: Overview of Nutex's population health management division

    C O N F I D E N T I A L 13 Overview of Nutex’s population health management division Definitions: ACO: Accountable Care Organization; CQM: Clinical Quality Measure; EHR: Electronic Health Record; HCC: Hierarchical Condition Categories; HMO: Health Maintenance Organization; IPA: Independent Practitio

  13. Slide 13: Population health division: Clinigence Health

    C O N F I D E N T I A L 14 Overview of Nutex’s population health management division ◼ Clinigence Health: ◼ Clients include IPAs ACOs, MSOs, payors, hospitals and physicians in over 30 states ◼ 3.5 Million active medical records on the platform ◼ Integrates both discrete clinical data and claims dat

  14. Slide 14: Population health division: ProCare MSO

    C O N F I D E N T I A L 15 Overview of Nutex’s population health management division ◼ ProCare MSO – ProCare is a full service Managed Services Organization (MSO) that operates in Southern and Northern California. ProCare understands that our Independent Physician Associations (IPA), Medical Groups,

  15. Slide 15: Population health division: Nutex IPAs

    C O N F I D E N T I A L 16 Overview of Nutex’s population health management division ◼ Nutex IPAs (Independent Practice Associations) ◼ An IPA is a network physicians that contracts with payors and manages the total care of patients ◼ Our IPAs are risk-bearing organizations: they assume either parti

  16. Slide 16: Vision: coordinated, integrated, risk-bearing care delivery model

    C O N F I D E N T I A L 17 Our vision is to create a coordinated, integrated, risk-bearing care delivery model First-of-its-kind integrated healthcare delivery model Future State Value-based care Today Micro-hospitals Technology enabled value-based network Patient-centric healthcare provider Network

  17. Slide 17: Nutex Health Differentiators

    C O N F I D E N T I A L 18 Nutex Health Differentiators ◼ Micro-Hospital ◼ Clean, new facilities with private rooms ◼ Reduced Emergency Department wait-times: average 15- 30 minutes versus hours ◼ 24/7/365 accessibility ◼ Increased patient convenience and patient satisfaction ◼ Higher reimbursement

  18. Slide 18: Our focus areas represent a massive market opportunity

    C O N F I D E N T I A L 19 Our focus areas represent a massive market opportunity Population Health Management Division I) Clinigence – cloud-based SaaS and data analytics enable providers to optimize clinical outcomes and financial performance II) Procare – an MSO that provides healthcare administr

  19. Slide 19: How we got here

    C O N F I D E N T I A L 20 Year 2015 2016 - 2018 2019-2020 2021-2023 # of Facilities 1 5 17 22 # of States1 1 1 8 9 Milestones Opened first micro-hospital facility in Texarkana, TX Continued expansion in Texas by adding 4 new facilities Strong de-novo growth; added 12 micro-hospitals across 7 new st

  20. Slide 20: Selected External Growth Opportunities

    C O N F I D E N T I A L 21 Selected External Growth Opportunities Strategic Geographies ▪ Enter new markets ▪ Add density in served markets ▪ Certificate of Need states Facility Development ▪ Acquire and transition facilities into micro-hospitals ▪ Hospital outpatient licensing ▪ Improve MLR on risk

  21. Slide 21: Nutex strategic response to the No Surprises Act

    C O N F I D E N T I A L 22 Nutex strategic response to the No Surprises Act (NSA) Our Strategic Response Actions: Maximizing our claims coding efficiency, increasing efforts to collect co-pays and co-insurance 1 6 Focus on growing IPA side of the business, which is minimally affected by the NSA 3 Ma

  22. Slide 22: Financial Overview: Historical Financials - Annual

    C O N F I D E N T I A L 23 Financial Overview Historical Financials - Annual Commentary ▪ FY2022 Hospital Division Revenue of $199mm ▪ FY2022 Population Health Division revenue of $21mm ▪ $34mm cash and equivalents as of 12/31/2022 ▪ Several initiatives underway to power a strong growth path ahead:

  23. Slide 23: Financial Overview: Historical Financials - Quarterly

    C O N F I D E N T I A L 24 Financial Overview Historical Financials - Quarterly Commentary ▪ Net revenue of $62.7 million for 3rd Quarter 2023. ▪ Net cash from operating activities of $2.0 million. ▪ Adjusted EBITDA of $1.3 million. ▪ As of September 30, 2023, the Company had total assets of $480 mi

  24. Slide 24: Board of Directors

    C O N F I D E N T I A L 25 Thomas T. Vo, M.D., MBA Chief Executive Officer John Waters Director and Chair of the Audit Committee Danniel Stites, M.D. Director Cheryl Grenas, R.N., MSN Director Mike Reed Director Mitchell Creem Director Warren Hosseinion, M.D. President and Director o Ms. Grenas curr

  25. Slide 25: Investment Highlights

    C O N F I D E N T I A L 26 Investment Highlights Well-positioned for major trends in a large and attractive market (high-quality, medium-acuity patient-centric hospital with inpatient care and value-based outpatient care) 1 Deep value proposition to the healthcare ecosystem from our comprehensive po

Nutex Health — Investor Presentation (January 2024) on 6ix